Virios Therapeutics, Inc. Profile Avatar - Palmy Investing

Virios Therapeutics, Inc.

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed d…

Biotechnology
US, Alpharetta [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

No VpE graphs at the moment.

Employee Surveys

Employees Asked: -

No survey available at the moment.

Talent Acquisition

Permanent Employees

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

Virios Therapeutics, Inc. can't present the data

Top Demand Within Q3:

Not available for Virios Therapeutics, Inc.

Temporary Employees H1Bs

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

Virios Therapeutics, Inc. can't present the data

Top Demand Within Q3:

    Not available for Virios Therapeutics, Inc.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of VIRI's Analysis
CIK: 1818844 CUSIP: 92829J104 ISIN: US92829J1043 LEI: - UEI: -
Secondary Listings
VIRI has no secondary listings inside our databases.